<DOC>
	<DOCNO>NCT01343914</DOCNO>
	<brief_summary>This retrospective observational study analyse demographic , clinical treatment-related data patient non-squamous non-small cell lung cancer ( NSCLC ) reach &gt; /= 9 month progression-free survival Avastin ( bevacizumab ) -based first-line therapy . Data collect approximately 9 month .</brief_summary>
	<brief_title>An Observational Study Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin ( Bevacizumab ) -Based First-Line Therapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Nonsquamous nonsmall cell lung cancer ( NSCLC ) treat firstline Avastinbased therapy Progressionfree survival &gt; /= 9 month reach</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>